Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2005 1
2006 4
2007 6
2008 11
2009 7
2010 10
2011 15
2012 16
2013 20
2014 21
2015 15
2016 9
2017 6
2018 7
2019 9
2020 4
2021 2
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

149 results

Results by year

Filters applied: . Clear all
Page 1
2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases.
Dures E, Farisoğulları B, Santos EJF, Molto A, Feldthusen C, Harris C, Elling-Audersch C, Connolly D, Elefante E, Estévez-López F, Bini I, Primdahl J, Hoeper K, Urban M, van de Laar MAFJ, Redondo M, Böhm P, Amarnani R, Hayward R, Geenen R, Rednic S, Pettersson S, Thomsen T, Uhlig T, Ritschl V, Machado PM. Dures E, et al. Among authors: van de laar mafj. Ann Rheum Dis. 2023 Nov 22:ard-2023-224514. doi: 10.1136/ard-2023-224514. Online ahead of print. Ann Rheum Dis. 2023. PMID: 38050029
Two parallel short forms to measure disease- and treatment-associated knowledge in rheumatoid arthritis: application of item response theory.
Spijk-de Jonge MJ, Oude Voshaar MAH, Renskers L, Huis AMP, van de Laar MAFJ, Hulscher MEJL, van Riel PLCM. Spijk-de Jonge MJ, et al. Among authors: van de laar mafj. Rheumatol Adv Pract. 2020 Jun 17;4(2):rkaa012. doi: 10.1093/rap/rkaa012. eCollection 2020. Rheumatol Adv Pract. 2020. PMID: 32704614 Free PMC article.
Cost-Effectiveness of a JAK1/JAK2 Inhibitor vs a Biologic Disease-Modifying Antirheumatic Drug (bDMARD) in a Treat-to-Target Strategy for Rheumatoid Arthritis.
Van De Laar CJ, Oude Voshaar MAH, Fakhouri WKH, Zaremba-Pechmann L, De Leonardis F, De La Torre I, Van De Laar MAFJ. Van De Laar CJ, et al. Among authors: van de laar mafj. Clinicoecon Outcomes Res. 2020 Apr 15;12:213-222. doi: 10.2147/CEOR.S231558. eCollection 2020. Clinicoecon Outcomes Res. 2020. PMID: 32346301 Free PMC article.
Common Functional Ability Score for Young People With Juvenile Idiopathic Arthritis.
Shoop-Worrall SJW, Oude Voshaar MAH, McDonagh JE, Van de Laar MAFJ, Wulffraat N, Thomson W, Hyrich KL, Verstappen SMM. Shoop-Worrall SJW, et al. Among authors: van de laar mafj. Arthritis Care Res (Hoboken). 2021 Jul;73(7):947-954. doi: 10.1002/acr.24204. Epub 2021 Jun 4. Arthritis Care Res (Hoboken). 2021. PMID: 32286729
149 results